The RESULTS Act: Updating Medicare Lab Test Payment Rules
September 10, 2025
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
Where This Stands
Currently in_committee. The next step in the legislative lifecycle is Floor Vote.
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →The Frame
This bill changes the data collection process used to set Medicare reimbursement rates for common lab tests, which affects how much Medicare pays laboratories and potentially impacts the availability of these tests for Medicare beneficiaries.
Potentially affected actors named in the source documents. Mention is not a position.
Clinical Diagnostic Laboratories
These entities will see changes to the data reporting requirements and the methodology used to determine their Medicare reimbursement rates.
Medicare Beneficiaries
These individuals may experience changes in the availability or access to diagnostic laboratory tests depending on how payment rate adjustments affect providers.
Department of Health and Human Services
The agency is tasked with contracting with an independent data entity and overseeing the new data collection process.
Current stage: in_committee.
Floor Vote.
Summary
Key Facts
- The bill is officially titled the 'Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025' or the 'RESULTS Act'.
- Starting January 1, 2028, the Secretary of Health and Human Services must use data from a 'qualifying independent claims data entity' to set payment rates for widely available, non-advanced diagnostic laboratory tests.
- The Secretary is required to contract with a national nonprofit organization to serve as the qualifying independent claims data entity.
- The bill extends the data collection period for certain laboratory test reporting requirements from 2025 to 2027.
- The reporting period for specific laboratory tests is adjusted to begin January 1, 2028, and end March 31, 2028.
- The definition of 'applicable laboratory' for reporting purposes is updated for periods beginning on or after January 1, 2028.
- Qualifying independent claims data entities must be national nonprofits, unaffiliated with health insurance or provider organizations, and compliant with HIPAA privacy laws.
- Qualifying databases must undergo quality assurance processes, including comprehensive statistical testing.
Why It Matters
This bill changes the data collection process used to set Medicare reimbursement rates for common lab tests, which affects how much Medicare pays laboratories and potentially impacts the availability of these tests for Medicare beneficiaries.
Frequently Asked Questions
How will this change Medicare payments for lab tests?
Who is considered a 'qualifying independent claims data entity'?
News Coverage
Lobbying Activity
NATURAL RESOURCE RESULTS LLC
on behalf of BONEFISH & TARPON TRUST
VENABLE LLP
on behalf of SUTTER HEALTH
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Outsourcing Data Collection
The bill represents a shift from government-mandated direct reporting by labs to the use of third-party, nonprofit-managed claims databases for setting Medicare rates.
Connected Entities
Analysis Score
0–100- Significance65How much this matters to a regular citizen
- Controversy20Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz15Current news / social attention level
Publisher tools